English | Español
Patient Daily | May 24, 2023

Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily Report | May 23, 2023

Doctor says innovative technology will 'provide the Type 1 diabetes community with additional options and flexibilities for diabetes management'
Patient Daily Report | May 23, 2023

Yale Professor Dr. Mona Gohara: 'As a dermatologist, I appreciate EltaMD moving the benchmark on this mission by enlisting Andy [Cohen] to spread this imperative message'
Patient Daily Report | May 23, 2023

Dr. Janet Maynard: new FDA-approved drug will 'provide an additional safe and effective option for women' experiencing hot flashes
Patient Daily Report | May 22, 2023

Local doctor on balloon sinuplasty: 'This procedure is minimally invasive, safe, painless, fast and effective'
Patient Daily | May 22, 2023

Vizzia Technologies Achieves SOC 2 Type II Compliance Certification for RTLS
Pacient Daily | May 22, 2023

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Pacient Daily | May 22, 2023

Clinical ink Work Demonstrating Technology Sensitivity to Parkinson’s Disease Published in Nature

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’